Somaxon management will host a conference call that same afternoon at 4:30 p.m. ET (1:30 p.m. PT) to review the financial results and answer questions.
In a release, the Company noted event details:
The conference call will be available to interested parties through a live audio Internet broadcast at: http://investors.somaxon.com/eventdetail.cfm. The call will also be archived and accessible at this site for approximately 14 days. Alternatively, callers may participate in the conference call by dialing (800) 762-8908 (domestic) or (480) 629-9774 (international). A telephonic replay will be available for approximately one week following the conclusion of the call by dialing (800) 406-7325 (domestic) or (303) 590-3030 (international), and entering passcode 4173742.
Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area.
((Comments on this story may be sent to newsdesk@closeupmedia.com))

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index